Comparison of the effects of bismuth-containing quadruple and standard triple therapy on Hp positive peptic ulcer
10.3969/j.issn.1005-1678.2017.01.075
- VernacularTitle:含铋剂的四联与标准三联法治疗Hp阳性型消化性溃疡患者的效果比较
- Author:
Ying CHEN
;
Nan LI
;
Linli FEI
;
Weiwei XU
- Keywords:
Hp positive type;
peptic ulcer;
Serum NO;
TGF-β1;
IL-10;
IL-17
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(1):251-253,256
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the changes of serum NO, TGF-β1, IL-10 and IL-17 Levels and study of the efficacy of Bismuth - containing quadruple and standard triple therapy for patients with Hp positive peptic ulcer. Methods 109 cases of peptic ulcer treated in our hospital were retrospectively selected, and Hp test was positive. According to different dosing regimen, the patients were divided into two groups. There were 54 patients in the control group, using standard triple therapy, and the regimen was lansoprazole, amoxicillin, and metronidazole. 55 patients in the study group were treated with bismuth-based western therapy with bismuth potassium citrate, rabeprazole, amoxicillin, and furazolidone. Two weeks after treatment were regarded as the observation period, and the levels of serum NO, TGF-β1, IL-10 and IL-17 in the two groups were compared before and after treatment. The effective rate of ulcer healing, Hp clearance rate and incidence of adverse reactions were compared. Results The level of serum NO, TGF-β1, IL-10 and IL-17 was significantly lower than that in the control group (P <0.05). The effective rates of ulcer healing and Hp clearance in the study group were significantly higher than those in the control group (P <0.05). There was no significant differences between the study group and the control group in the incidence of adverse reactions. Conclusion Western medicine with bismuth in the treatment of Hp peptic ulcer patients, the serum NO, TGF-β1, IL-10 and IL-17 levels of indicators have significantly improved, and has obvious advantages in clinical treatment, and it is a reasonable dosing regimen of high efficiency and low recurrence.
